180 related articles for article (PubMed ID: 26460615)
1. Deciphering the molecular basis of invasiveness in Sdhb-deficient cells.
Loriot C; Domingues M; Berger A; Menara M; Ruel M; Morin A; Castro-Vega LJ; Letouzé É; Martinelli C; Bemelmans AP; Larue L; Gimenez-Roqueplo AP; Favier J
Oncotarget; 2015 Oct; 6(32):32955-65. PubMed ID: 26460615
[TBL] [Abstract][Full Text] [Related]
2. Epithelial to mesenchymal transition is activated in metastatic pheochromocytomas and paragangliomas caused by SDHB gene mutations.
Loriot C; Burnichon N; Gadessaud N; Vescovo L; Amar L; Libé R; Bertherat J; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP; Favier J
J Clin Endocrinol Metab; 2012 Jun; 97(6):E954-62. PubMed ID: 22492777
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic Deregulation of Protocadherin PCDHGC3 in Pheochromocytomas/Paragangliomas Associated With SDHB Mutations.
Bernardo-Castiñeira C; Valdés N; Celada L; Martinez ASJ; Sáenz-de-Santa-María I; Bayón GF; Fernández AF; Sierra MI; Fraga MF; Astudillo A; Jiménez-Fonseca P; Rial JC; Hevia MÁ; Turienzo E; Bernardo C; Forga L; Tena I; Molina-Garrido MJ; Cacho L; Villabona C; Serrano T; Scola B; Chirivella I; Del Olmo M; Menéndez CL; Navarro E; Tous M; Vallejo A; Athimulam S; Bancos I; Suarez C; Chiara MD
J Clin Endocrinol Metab; 2019 Nov; 104(11):5673-5692. PubMed ID: 31216007
[TBL] [Abstract][Full Text] [Related]
4. Role of microenvironment on neuroblastoma SK-N-AS SDHB-silenced cell metabolism and function.
Rapizzi E; Fucci R; Giannoni E; Canu L; Richter S; Cirri P; Mannelli M
Endocr Relat Cancer; 2015 Jun; 22(3):409-17. PubMed ID: 25808177
[TBL] [Abstract][Full Text] [Related]
5. Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas.
Klein RD; Jin L; Rumilla K; Young WF; Lloyd RV
Diagn Mol Pathol; 2008 Jun; 17(2):94-100. PubMed ID: 18382370
[TBL] [Abstract][Full Text] [Related]
6. The aggressiveness of succinate dehydrogenase subunit B-deficient chromaffin cells is reduced when their bioelectrical properties are restored by glibenclamide.
Amore F; Garella R; Santi A; Guasti D; Martinelli S; Canu L; Bani D; Neuzil J; Maggi M; Squecco R; Rapizzi E
Endocr Relat Cancer; 2023 Oct; 30(10):. PubMed ID: 37493200
[TBL] [Abstract][Full Text] [Related]
7. SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma/paraganglioma.
Menara M; Oudijk L; Badoual C; Bertherat J; Lepoutre-Lussey C; Amar L; Iturrioz X; Sibony M; Zinzindohoué F; de Krijger R; Gimenez-Roqueplo AP; Favier J
J Clin Endocrinol Metab; 2015 Feb; 100(2):E287-91. PubMed ID: 25405498
[TBL] [Abstract][Full Text] [Related]
8. SDH mutations establish a hypermethylator phenotype in paraganglioma.
Letouzé E; Martinelli C; Loriot C; Burnichon N; Abermil N; Ottolenghi C; Janin M; Menara M; Nguyen AT; Benit P; Buffet A; Marcaillou C; Bertherat J; Amar L; Rustin P; De Reyniès A; Gimenez-Roqueplo AP; Favier J
Cancer Cell; 2013 Jun; 23(6):739-52. PubMed ID: 23707781
[TBL] [Abstract][Full Text] [Related]
9. Targeting pheochromocytoma/paraganglioma with polyamine inhibitors.
Rai SK; Bril F; Hatch HM; Xu Y; Shelton L; Kalavalapalli S; Click A; Lee D; Beecher C; Kirby A; Kong K; Trevino J; Jha A; Jatav S; Kriti K; Luthra S; Garrett TJ; Guingab-Cagmat J; Plant D; Bose P; Cusi K; Hromas RA; Tischler AS; Powers JF; Gupta P; Bibb J; Beuschlein F; Robledo M; Calsina B; Timmers H; Taieb D; Kroiss M; Richter S; Langton K; Eisenhofer G; Bergeron R; Pacak K; Tevosian SG; Ghayee HK
Metabolism; 2020 Sep; 110():154297. PubMed ID: 32562798
[TBL] [Abstract][Full Text] [Related]
10. Increased SSTR2A and SSTR3 expression in succinate dehydrogenase-deficient pheochromocytomas and paragangliomas.
Elston MS; Meyer-Rochow GY; Conaglen HM; Clarkson A; Clifton-Bligh RJ; Conaglen JV; Gill AJ
Hum Pathol; 2015 Mar; 46(3):390-6. PubMed ID: 25554089
[TBL] [Abstract][Full Text] [Related]
11. 15 YEARS OF PARAGANGLIOMA: Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations.
Baysal BE; Maher ER
Endocr Relat Cancer; 2015 Aug; 22(4):T71-82. PubMed ID: 26113606
[TBL] [Abstract][Full Text] [Related]
12. Primary fibroblast co-culture stimulates growth and metabolism in Sdhb-impaired mouse pheochromocytoma MTT cells.
Richter S; D'Antongiovanni V; Martinelli S; Bechmann N; Riverso M; Poitz DM; Pacak K; Eisenhofer G; Mannelli M; Rapizzi E
Cell Tissue Res; 2018 Dec; 374(3):473-485. PubMed ID: 30159755
[TBL] [Abstract][Full Text] [Related]
13. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical Staining for SOX10 and SDHB in SDH-Deficient Paragangliomas Indicates that Sustentacular Cells Are Not Neoplastic.
Powers JF; Tischler AS
Endocr Pathol; 2020 Sep; 31(3):307-309. PubMed ID: 32562155
[No Abstract] [Full Text] [Related]
15. From Nf1 to Sdhb knockout: Successes and failures in the quest for animal models of pheochromocytoma.
Lepoutre-Lussey C; Thibault C; Buffet A; Morin A; Badoual C; Bénit P; Rustin P; Ottolenghi C; Janin M; Castro-Vega LJ; Trapman J; Gimenez-Roqueplo AP; Favier J
Mol Cell Endocrinol; 2016 Feb; 421():40-8. PubMed ID: 26123588
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.
Gill AJ; Benn DE; Chou A; Clarkson A; Muljono A; Meyer-Rochow GY; Richardson AL; Sidhu SB; Robinson BG; Clifton-Bligh RJ
Hum Pathol; 2010 Jun; 41(6):805-14. PubMed ID: 20236688
[TBL] [Abstract][Full Text] [Related]
17. LncRNA expression and SDHB mutations in pheochromocytomas and paragangliomas.
Li H; Hardin H; Zaeem M; Huang W; Hu R; Lloyd RV
Ann Diagn Pathol; 2021 Dec; 55():151801. PubMed ID: 34461576
[TBL] [Abstract][Full Text] [Related]
18. Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas.
Amar L; Baudin E; Burnichon N; Peyrard S; Silvera S; Bertherat J; Bertagna X; Schlumberger M; Jeunemaitre X; Gimenez-Roqueplo AP; Plouin PF
J Clin Endocrinol Metab; 2007 Oct; 92(10):3822-8. PubMed ID: 17652212
[TBL] [Abstract][Full Text] [Related]
19. Succinate-to-fumarate ratio as a new metabolic marker to detect the presence of SDHB/D-related paraganglioma: initial experimental and ex vivo findings.
Lendvai N; Pawlosky R; Bullova P; Eisenhofer G; Patocs A; Veech RL; Pacak K
Endocrinology; 2014 Jan; 155(1):27-32. PubMed ID: 24189137
[TBL] [Abstract][Full Text] [Related]
20. SDHB knockout and succinate accumulation are insufficient for tumorigenesis but dual SDHB/NF1 loss yields SDHx-like pheochromocytomas.
Armstrong N; Storey CM; Noll SE; Margulis K; Soe MH; Xu H; Yeh B; Fishbein L; Kebebew E; Howitt BE; Zare RN; Sage J; Annes JP
Cell Rep; 2022 Mar; 38(9):110453. PubMed ID: 35235785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
